1. Medtech Insight
  2. >>Geography

Device Debut: Zimmer Biomet's Sidus Stemless Shoulder Will Take On Wright's Simpliciti

 
• By Reed Miller

US FDA cleared the Sidus total shoulder arthroplasty system for patients with "good bone stock" who have osteoarthritis, posttraumatic arthrosis, focal avascular necrosis of the humeral head, or a previous shoulder surgery that does not compromise the fixation. The company is planning to launch it in the US by the end of the quarter.

Zimmer Biomet Holdings Inc., the leader in the US shoulder replacement market, will soon compete with Wright Medical Group NV in the bone-sparing shoulder segment of the US orthopedics market.

US FDA 510(k)-clearedZimmer Biomet Holdings Inc.'s Sidus stem-free shoulder system for total shoulder arthroplasty, and the company plans to launch it in the US market within the first quarter, the company announced on Jan. 3. Sidus will compete with Wright's Simpliciti bone-sparing shoulder system. Simpliciti was originally developed by Tornier NV, and earned a 510(k) in March 2015 shortly before Wright acquired Tornier for $3.3bn

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America